Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × Carboplatin × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 291 Fallopian Tube Neoplasms 145 Carcinoma, Ovarian Epithelial 107 Endometrial Neoplasms 65 Uterine Cervical Neoplasms 61 Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Brenner Tumor 20 Breast Neoplasms 20 Recurrence 18 Testicular Neoplasms 14 Stomach Neoplasms 14 Peritoneal Neoplasms 14 Pancreatic Neoplasms 11 Urinary Bladder Neoplasms 10 Colorectal Neoplasms 10 Sarcoma 9 Triple Negative Breast Neoplasms 8 Testicular Germ Cell Tumor 8 Teratoma 8 Squamous Cell Carcinoma of Head and Neck 8 Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Ovarian Germ Cell Cancer 8 Neoplasm Metastasis 8 Central Nervous System Neoplasms 8 Uterine Neoplasms 7 Neuroectodermal Tumors, Primitive, Peripheral 7 Lung Neoplasms 7 Esophageal Neoplasms 6 Small Cell Lung Carcinoma 5

Interventions

Saline Solution 3 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 niraparib 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡